Abstract |
In this issue of Blood, Pegram and colleagues describe the ability to improve adoptive T-cell therapies by engineering T cells to secrete the potent proinflammatory cytokine IL-12.1 These exciting findings significantly extend previous observations made in a murine melanoma model targeting naturally occurring tumor antigens.2,3
|
Authors | Sid P Kerkar, Nicholas P Restifo |
Journal | Blood
(Blood)
Vol. 119
Issue 18
Pg. 4096-7
(May 03 2012)
ISSN: 1528-0020 [Electronic] United States |
PMID | 22555659
(Publication Type: Comment, Journal Article)
|